Investment
Features
FeesSafety
Academy
More
Pluang+

Teladoc faces securities fraud probe after cutting 2026 revenue forecast, shares plunge 38%.

Market News
06 Aug 2026
PRNewsWire
View Source
Bearish
pluang ai news

Teladoc Health announced a lowered revenue forecast for 2026, citing challenges in its cash pay model and pressures on its BetterHelp platform. Following this, its stock price dropped sharply by 38.32%. Pomerantz LLP has launched an investigation into whether Teladoc and its executives engaged in securities fraud or other unlawful practices. Investors affected by the stock decline are encouraged to contact the law firm as the case develops.

More News (TDOC)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App